TNF and early-onset autosomal dominant Alzheimer disease: Overall, our results point to complex interactions during Alzheimer’s disease initiation in vivo, with early stage inflammation, either from the disease itself, or secondary insults, leading to TNF release and subsequent acceleration of the release of protein aggregates, which in turn drives further disease progression.